Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PHIBRO ANIMAL HEALTH CORPPAHC · Entity 4671 | SVP, Gen Counsel & Corp Secy | June 01, 2017 | June 05, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PHIBRO ANIMAL HEALTH CORP
Report date June 01, 2017 · Filed June 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-06-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-06-01 · Exercise / conversion · Acquired 1,150 · Balance 1,150 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Row 2 · 2017-06-01 · Exercise / conversion · Acquired 11,050 · Balance 12,200 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Row 3 · 2017-06-01 · Sale · Disposed 12,200 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $36.38. |
| Option to purchase Class A Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2019-02-28 | Direct | 0 |
Reported balance
After 2017-06-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-06-01 · Exercise / conversion · Disposed 1,150 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. |
| Option to purchase Class A Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2019-02-28 | Direct | 0 |
Reported balance
After 2017-06-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-06-01 · Exercise / conversion · Disposed 11,050 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $36.38.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2017 Filed Jun 5, 2017 22:41 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 11,050 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-005703 · t1704006_f4-dagger.xml · derivative · entry 5 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 11,050 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 22:41 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 1,150 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-005703 · t1704006_f4-dagger.xml · derivative · entry 4 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,150 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 22:41 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 12,200 | $35.76 | $436,272.00 |
DisclosureSEC source: 0001571049-17-005703 · t1704006_f4-dagger.xml · nonDerivative · entry 3 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $36.38. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 22:41 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 11,050 | $11.83 | $130,721.50 |
DisclosureSEC source: 0001571049-17-005703 · t1704006_f4-dagger.xml · nonDerivative · entry 2 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 22:41 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 1,150 | $11.83 | $13,604.50 |
DisclosureSEC source: 0001571049-17-005703 · t1704006_f4-dagger.xml · nonDerivative · entry 1 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel & Corp Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| May 09, 2017 Filed May 12, 2017 01:03 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 8,000 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-004903 · t1701553_x2-dagger.xml · derivative · entry 3 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel and Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Underlying: Class A Common Stock · 8,000 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| May 09, 2017 Filed May 12, 2017 01:03 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 8,000 | $32.13 | $257,040.00 |
DisclosureSEC source: 0001571049-17-004903 · t1701553_x2-dagger.xml · nonDerivative · entry 2 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel and Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.55 Read SEC document |
| May 09, 2017 Filed May 12, 2017 01:03 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 8,000 | $11.83 | $94,640.00 |
DisclosureSEC source: 0001571049-17-004903 · t1701553_x2-dagger.xml · nonDerivative · entry 1 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel and Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 1,900 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001290 · t1700411_x2.xml · derivative · entry 5 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel and Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,150 Underlying: Class A Common Stock · 1,900 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 5,893 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001290 · t1700411_x2.xml · derivative · entry 4 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel and Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,993 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 5,893 | $30.27 | $178,381.11 |
DisclosureSEC source: 0001571049-17-001290 · t1700411_x2.xml · nonDerivative · entry 3 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel and Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.45. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 1,900 | $11.83 | $22,477.00 |
DisclosureSEC source: 0001571049-17-001290 · t1700411_x2.xml · nonDerivative · entry 2 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel and Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Reflects conversion of options with an exercisable date of March 1, 2013. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 01:33 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 3,993 | $11.83 | $47,237.19 |
DisclosureSEC source: 0001571049-17-001290 · t1700411_x2.xml · nonDerivative · entry 1 Dagger Thomas G · CIK 0001601340 · SVP, Gen Counsel and Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects conversions of options with an exercisable date of March 1, 2012. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 7 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-000212 · t1700038-x1.xml · derivative · entry 6 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,993 Underlying: Class A Common Stock · 7 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 7 | $30.00 | $210.00 |
DisclosureSEC source: 0001571049-17-000212 · t1700038-x1.xml · nonDerivative · entry 4 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 7 | $11.83 | $82.81 |
DisclosureSEC source: 0001571049-17-000212 · t1700038-x1.xml · nonDerivative · entry 3 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 200 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-000212 · t1700038-x1.xml · derivative · entry 5 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Class A Common Stock · 200 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 200 | $30.00 | $6,000.00 |
DisclosureSEC source: 0001571049-17-000212 · t1700038-x1.xml · nonDerivative · entry 2 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 200 | $11.83 | $2,366.00 |
DisclosureSEC source: 0001571049-17-000212 · t1700038-x1.xml · nonDerivative · entry 1 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 02:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 1,700 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-16-020776 · t1603145_x1.xml · derivative · entry 6 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200 Underlying: Class A Common Stock · 1,700 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 02:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 1,700 | $30.03 | $51,051.00 |
DisclosureSEC source: 0001571049-16-020776 · t1603145_x1.xml · nonDerivative · entry 4 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 02:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 1,700 | $11.83 | $20,111.00 |
DisclosureSEC source: 0001571049-16-020776 · t1603145_x1.xml · nonDerivative · entry 3 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| December 19, 2016 Filed Dec 22, 2016 02:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 200 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-16-020776 · t1603145_x1.xml · derivative · entry 5 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Underlying: Class A Common Stock · 200 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
| December 19, 2016 Filed Dec 22, 2016 02:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 200 | $30.01 | $6,002.00 |
DisclosureSEC source: 0001571049-16-020776 · t1603145_x1.xml · nonDerivative · entry 2 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. Read SEC document |
| December 19, 2016 Filed Dec 22, 2016 02:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 200 | $11.83 | $2,366.00 |
DisclosureSEC source: 0001571049-16-020776 · t1603145_x1.xml · nonDerivative · entry 1 Dagger Thomas G · CIK 0001601340 · SVP, GC and Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.